Alaunos Therapeutics, Inc. (TCRT)
1.855
+0.02
(+0.82%)
USD |
NASDAQ |
Nov 06, 09:58
Alaunos Therapeutics Market Cap : 4.612M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 4.574M |
| November 04, 2026 | 4.475M |
| November 03, 2026 | 4.624M |
| November 02, 2026 | 4.351M |
| October 30, 2026 | 4.848M |
| October 29, 2026 | 4.699M |
| October 28, 2026 | 5.295M |
| October 27, 2026 | 5.121M |
| October 26, 2026 | 5.295M |
| October 23, 2026 | 5.668M |
| October 22, 2026 | 7.558M |
| October 21, 2026 | 7.657M |
| October 20, 2026 | 7.384M |
| October 19, 2026 | 7.782M |
| October 16, 2026 | 6.538M |
| October 15, 2026 | 5.420M |
| October 14, 2026 | 5.146M |
| October 13, 2026 | 7.533M |
| October 12, 2026 | 2.610M |
| October 09, 2026 | 1.954M |
| October 08, 2026 | 1.942M |
| October 07, 2026 | 2.084M |
| October 06, 2026 | 1.846M |
| October 05, 2026 | 1.977M |
| October 02, 2026 | 2.039M |
| Date | Value |
|---|---|
| October 01, 2026 | 2.287M |
| September 30, 2026 | 2.206M |
| September 29, 2026 | 2.388M |
| September 28, 2026 | 2.536M |
| September 25, 2026 | 2.710M |
| September 24, 2026 | 2.809M |
| September 23, 2026 | 2.859M |
| September 22, 2026 | 3.157M |
| September 21, 2026 | 3.132M |
| September 18, 2026 | 2.983M |
| September 17, 2026 | 3.978M |
| September 16, 2026 | 3.182M |
| September 15, 2026 | 3.505M |
| September 14, 2026 | 3.704M |
| September 11, 2026 | 3.754M |
| September 10, 2026 | 3.877M |
| September 09, 2026 | 3.878M |
| September 08, 2026 | 3.903M |
| September 04, 2026 | 4.052M |
| September 03, 2026 | 4.102M |
| September 02, 2026 | 4.152M |
| September 01, 2026 | 4.127M |
| August 31, 2026 | 4.226M |
| August 28, 2026 | 3.990M |
| August 27, 2026 | 4.127M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 277.43M |
| Amgen, Inc. | 248.02B |
| Anika Therapeutics, Inc. | 226.84M |
| BioCryst Pharmaceuticals, Inc. | 1.925B |
| Imunon, Inc. | 4.082M |
Market Cap Related Metrics
| PS Ratio | 1377.74 |
| Price to Book Value | 7.073 |
| Price | 1.855 |
| Earnings Yield | -105.0% |